Moviprep®

DRUG4 trials

Sponsors

Fraunhofer Institute For Translational Medicine And Pharmacology ITMP, University Hospital, Ghent, Norgine, Sebela Pharmaceuticals Development LLC

Conditions

Colon Prep for ColonoscopyColorectal Cleansing Prior OperationGastric EmptyingHealthyIntestinal colonization with vancomycin-resistant enterococci (VRE)

Phase 1

Scintigraphic Assessment Following Klean-Prep® or Moviprep®

CompletedNCT00896246

NorgineGastric Emptying, Healthy

Start: 2006-09-30End: 2006-11-30Updated: 2009-05-12

Phase 2

Safety and Efficacy Study of an Edible Colonoscopy Preparation

CompletedNCT03332485

Sebela Pharmaceuticals Development LLCColon Prep for Colonoscopy

Start: 2017-11-20End: 2018-03-14Updated: 2018-03-19

Randomized Controlled Trial Assessing the Effectiveness and Safety of Fecal Microbiota Transfer for VRE Eradication in Immunocompromised Patients (EU CTR, Phase II) – VRE-ex

Not yet recruitingCTIS2026-525632-41-00

Fraunhofer Institute For Translational Medicine And Pharmacology ITMPIntestinal colonization with vancomycin-resistant enterococci (VRE)

Target: 42Updated: 2026-07-21

Phase 4

Moviprep® Versus Fleet Phospho-Soda® (Golden Standard): A Study That Compared Two Laxatives on Patients Undergoing Colo-Rectal Cleansing Prior to an Abdominal Operation

CompletedNCT00618930

University Hospital, GhentColorectal Cleansing Prior Operation

Start: 2008-02-29End: 2009-01-31Updated: 2009-04-15